John L. Higgins
2018
In 2018, John L. Higgins earned a total compensation of $6.3M as Chief Executive Officer at Ligand Pharmaceuticals, a 14% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $517,615 |
|---|---|
| Option Awards | $2,376,729 |
| Salary | $627,413 |
| Stock Awards | $2,779,081 |
| Other | $5,965 |
| Total | $6,306,803 |
Higgins received $2.8M in stock awards, accounting for 44% of the total pay in 2018.
Higgins also received $517.6K in non-equity incentive plan, $2.4M in option awards, $627.4K in salary and $6K in other compensation.
Rankings
In 2018, John L. Higgins' compensation ranked 1,458th out of 14,244 executives tracked by ExecPay. In other words, Higgins earned more than 89.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,458 out of 14,244 | 90th |
Division Manufacturing | 510 out of 5,759 | 91st |
Major group Chemicals And Allied Products | 161 out of 2,122 | 92nd |
Industry group Drugs | 126 out of 1,811 | 93rd |
Industry Pharmaceutical Preparations | 92 out of 1,385 | 93rd |
Source: SEC filing on April 24, 2020.
Higgins' colleagues
We found three more compensation records of executives who worked with John L. Higgins at Ligand Pharmaceuticals in 2018.